Venture Certified
| 혁신성장유형 | 2022-11-02 ~ 2025-11-01 | 20221102030132 | 2022-11-02 |
| 혁신성장유형 | 2025-11-02 ~ 2028-11-01 | 20251203030006 | 2022-11-02 |
Revenue CAGR +20.7%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 106B | 92B | 73B |
| Operating Profit | 6.5B | 5.4B | 4.2B |
| Net Profit | 6.1B | 5.2B | 3.9B |
| Total Assets | 53B | 45B | 38B |
| Total Liabilities | 32B | 31B | 27B |
| Total Equity | 21B | 15B | 10B |
▲ 28.5%
▲ 35.9%
▲ 5.9%
▼ 34.3%
▼ 19.2%
| Name | Position | Role |
|---|---|---|
| 손원서 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 강동구",
"ceo_name": "손원서",
"certificate": [
{
"cert_number": "20221102030132",
"changes": "",
"disclosure_date": "2022-11-02",
"first_cert_date": "2022-11-02",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2022-11-02 ~ 2025-11-01"
},
{
"cert_number": "20251203030006",
"changes": "",
"disclosure_date": "2025-12-03",
"first_cert_date": "2022-11-02",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2025-11-02 ~ 2028-11-01"
}
],
"company_name": "(주)인터렉스",
"corp_no": "131111-*******",
"financials": {
"2022": {
"capital_stock": 100000000,
"cost_of_sales": 5871607000,
"current_assets": 3625800000,
"current_liabilities": 1947627000,
"gross_profit": 1409277000,
"net_income": 390891000,
"net_income_bs": 354549000,
"non_current_assets": 134391000,
"non_current_liabilities": 800000000,
"non_operating_expenses": 33892000,
"non_operating_income": 9053000,
"operating_profit": 415730000,
"revenue": 7280884000,
"sga_expenses": 993547000,
"total_assets": 3760192000,
"total_equity": 1012565000,
"total_liabilities": 2747627000
},
"2023": {
"capital_stock": 100000000,
"cost_of_sales": 7448346000,
"current_assets": 4371991000,
"current_liabilities": 1983368000,
"gross_profit": 1787148000,
"net_income": 517218000,
"net_income_bs": 481216000,
"non_current_assets": 172658000,
"non_current_liabilities": 1067500000,
"non_operating_expenses": 57676000,
"non_operating_income": 32845000,
"operating_profit": 542049000,
"revenue": 9235494000,
"sga_expenses": 1245099000,
"total_assets": 4544649000,
"total_equity": 1493781000,
"total_liabilities": 3050868000
},
"2024": {
"capital_stock": 100000000,
"cost_of_sales": 8582743000,
"current_assets": 5027918000,
"current_liabilities": 2374867000,
"gross_profit": 2026580000,
"net_income": 611821000,
"net_income_bs": 573222000,
"non_current_assets": 266302000,
"non_current_liabilities": 852350000,
"non_operating_expenses": 54477000,
"non_operating_income": 15700000,
"operating_profit": 650598000,
"revenue": 10609323000,
"sga_expenses": 1375981000,
"total_assets": 5294220000,
"total_equity": 2067003000,
"total_liabilities": 3227217000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [],
"main_products": "지혈지지대,국소지혈용드레싱",
"phone": "02-511-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |